Valuation Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-02 EDT			5-day change	1st Jan Change
28.52 ^USD	+3.17%		+9.17%	-7.42%

07-03	Nordic stocks in North America, Ericsson fell 1.6%	FW
07-01	Nordic stocks in North America, AstraZeneca rose 1.3%	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	172,063	192,229	140,770	94,810	124,862	114,714	-	-
Change	-	11.72%	-26.77%	-32.65%	31.7%	-8.13%	-	-
Enterprise Value (EV) ¹	152,725	169,905	112,635	73,709	114,029	134,236	127,200	115,347
Change	-	11.25%	-33.71%	-34.56%	54.7%	17.72%	-5.24%	-9.32%
P/E	57.8x	35.2x	32.6x	12.3x	20.9x	24.5x	17.2x	11.3x
PBR	7.82x	7.07x	4.5x	2.68x	3.47x	2.81x	2.41x	2x
PEG	-	0.4x	-1.5x	0.1x	-1x	-1.1x	0.4x	0.2x
Capitalization / Revenue	20.3x	13.2x	8.54x	4.4x	5.31x	4.14x	3.53x	2.92x
EV / Revenue	18x	11.6x	6.84x	3.42x	4.85x	4.84x	3.92x	2.94x
EV / EBITDA	46.8x	25.3x	20.1x	10.4x	15.9x	16x	11.2x	7.08x
EV / EBIT	50.6x	26.7x	21.2x	10.5x	17x	18x	13.3x	8.36x
EV / FCF	77.3x	47.3x	16.1x	9.72x	15.7x	21.8x	13.6x	7.44x
FCF Yield	1.29%	2.12%	6.23%	10.3%	6.36%	4.58%	7.36%	13.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	45.54	83.65	66.02	121.4	97.08	76.26	108.7	164.7
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	8,482	14,595	16,474	21,526	23,497	27,732	32,453	39,246
EBITDA ¹	3,266	6,719	5,616	7,116	7,175	8,367	11,343	16,295
EBIT ¹	3,018	6,357	5,321	7,003	6,727	7,451	9,598	13,798
Net income ¹	3,008	5,522	4,352	7,844	6,083	4,763	7,030	10,572
Net Debt ¹	-19,338	-22,324	-28,135	-21,101	-10,833	19,522	12,487	633.6
Reference price ²	2,630.00	2,941.00	2,155.00	1,492.50	2,027.00	1,868.50	1,868.50	1,868.50
Nbr of stocks (in thousands)	65,423	65,362	65,322	63,524	61,599	61,393	-	-
Announcement Date	2/16/22	2/22/23	2/14/24	2/12/25	2/17/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ARGENX SE	35.79x	9x	27.97x	0.05%	58.73B
WUXI APPTEC CO., LTD.	20.24x	6.22x	13.5x	1.49%	53.92B
BIONTECH SE	-19.35x	4.94x	-8.63x	-.--%	24.67B
INSMED INCORPORATED	-42.26x	14x	-40.82x	-.--%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	23.43x	4.62x	11.99x	-.--%	18.8B
PHARMAESSENTIA CORPORATION	48.53x	19.97x	52.67x	0.06%	16.25B
EXELIXIS, INC.	17.56x	5.1x	11.91x	-.--%	14.04B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-488.19x	33.47x	-3731.69x	-.--%	13.9B
MADRIGAL PHARMACEUTICALS, INC.	-75.74x	7.79x	-69.83x	-.--%	12.18B
Average	-53.33x	11.68x	-414.77x	0.18%	26.3B
Weighted average by Cap.	-19.18x	10.00x	-212.58x	0.36%